Analyst Ratings For NYSE:MYOV – Myovant Sciences (NYSE:MYOV)
Today, Citigroup raised its price target on NYSE:MYOV – Myovant Sciences (NYSE:MYOV) to $44.00 per share.
Some recent analyst ratings include
- 4/5/2018-Barclays was Downgraded by analysts at Barclays from a “Overweight ” rating to a ” Equal Weight” rating. They now have a $18.00 price target on the stock.
- 11/14/2017-Cowen Reiterated Rating of Buy.
- 11/10/2017-Robert W. Baird Reiterated Rating of Buy.
- 10/4/2017-JMP Securities Reiterated Rating of Outperform.
- 8/16/2017-Evercore ISI initiated coverage with a Outperform rating.
Recent Insider Trading Activity For NYSE:MYOV – Myovant Sciences (NYSE:MYOV)
NYSE:MYOV – Myovant Sciences (NYSE:MYOV) has insider ownership of 3.00% and institutional ownership of 81.44%.
- On 4/2/2018 Holdings Ltd. Dexxon, Major Shareholder, bought 1,110,015 with an average share price of $20.27 per share and the total transaction amounting to $22,500,004.05.
- On 3/19/2018 Pharmaceuticals Interna Takeda, Major Shareholder, bought 7,420,625 with an average share price of $18.67 per share and the total transaction amounting to $138,543,068.75.
Recent Trading Activity for NYSE:MYOV – Myovant Sciences (NYSE:MYOV)
Shares of NYSE:MYOV – Myovant Sciences closed the previous trading session at 19.71 up +0.51 2.66% with shares trading hands.
